Company news

EMvision Medical Devices Ltd. news in 2026

EMvision Medical Devices Ltd.'s news releases, calls and decks from 2026, newest first.

View company

Quarterly Activities/Appendix 4C Cash Flow Report

October 25, 2026

$4.3m Non-Dilutive R&D Tax Rebate Received

September 27, 2026

First Responder Successfully Trialled with MSU

September 15, 2026

emu Regional Benefits Study Advancing

September 2, 2026

emu Pivotal Trial Recruitment Surpasses 200 Patients

August 30, 2026

Appendix 4E & Annual Report to 30 June 2026

August 23, 2026

Aeromedical Study De-Risks Rural & Remote Stroke Use Cases

May 26, 2026

EMVision to Receive $1.17M IGP Grant Instalment

May 24, 2026

emu Pivotal Trial Expansion Adds Acute Ischaemia Detection

May 10, 2026

$3.8m R&D Rebate Received & Overseas Finding Approved

March 15, 2026

Update - S&P DJI March 2026 Rebalance of the All Ordinaries

March 10, 2026

S&P DJI Announces March 2026 Quarterly Rebalance

March 6, 2026

EMVision Medical Devices to Present at Australia Investor Day February 26th

February 24, 2026

Half Yearly Report and Accounts

February 22, 2026

Quarterly Activities/Appendix 4C Cash Flow Report

January 27, 2026

Strong emu Clinical Trial & Program Progress

January 26, 2026

Decks in 2026